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Progression of renal failure in patients with renal disease of diverse
etiology on protein-restricted diet. The rate of progression of early renal
failure was evaluated in three groups of adult patients with renal disease
of diverse etiology on dietary protein and phosphorus restriction (about
0.6 glkg of protein, 700 mg of phosphorus) and in a control group of 22
patients with the same renal disease, retrospectively studied, on a free
diet. Group 1 had 33 patients with chronic glomerulonephritis (CG),
initial serum creatinine (Scr) of 1.4 to 4.3 mgldl (mean, 2.20), followed
for 5 to 94 months (mean, 44). Group 2 had 17 patients with polycystic
kidney disease (PKD), Scr 1.3 to 4.7 mgldl (mean, 2.40), followed for 8
to 81 months (mean, 42). Group 3 had 28 patients with primary chronic
pyelonephritis (CP), Scr of 1.5 to 4.5 mg/dl (mean, 2.57), followed for 9
to 92 months (mean, 41). The control group had 22 patients (11 with CG,
five with PKD, and six with CP), with Scr 1.7 to 4.1 mg/dl, followed for
6 to 72 months (mean, 24). In the regression analysis between reciprocal
creatinine and time, the slopes were —0.0017, —0.0025, and —0.00016
dI/mglmonth in the three patient groups on a protein-restricted diet,
respectively. The difference between both groups 1 and 2 and group 3
was statistically significant (P < 0.05). The slopes in patients on a free
diet were significantly greater than those found in patients on a
protein-restricted diet. The actuarial survival probability at 72 months,
assuming as "renal death" a Scr of 10 mg/dl, was 45% in patients with
CG, 44% in those with PKD, and 67% in those with CP on a
protein-restricted diet. Proteinuria and hypertension were the major
factors affecting the progression of renal failure in all patient groups.
With this dietary regimen, substantial percentages of patients (51% in
group 1, 41% in group 2, and 68% in group 3) had no progression of
functional deterioration during followup.
Progression de l'insuffisance rénale chez des malades atteints de
néphropathies de causes diverses en régime restreint en protides. La
vitesse de progression d'une insuffisance rénale précoce a été évaluée
dans trois groupes d'adultes atteints de néphropathies de causes
diverses en restriction alimentaire en protides et phosphore (environ o,6
g/kg de protides, 700mg de phosphore) et dans un groupe contrôle de 22
malades atteints des mimes néphropathies, étudiés rétrospectivement
en régime libre. Le groupe 1 comprenait 33 malades atteints de
glomérulonéphrite chronique (CG), avec créatininémies initiales de 1,4
a 4,3 mg/dl (moyenne, 2,20), suivis pendant 5 a 94 mois (moyenne, 44).
Le groupe 2 comprenait 17 malades atteints de polykystose rénale
(PKD), avec Scr de 1,3 a 4,7 mg/dl(moyenne, 2,4) suivis pendant 8 a 81
mois (moyenne, 42). Le groupe 3 comprenait 28 malades atteints de
pyélonéphrite chronique primitive (CP), Scr de 1,5 a 4,5 mg/dl(moyenne, 2,57) suivis de 9 a 92 mois (moyenne, 41). Le groupe
contrôle comprenait 22 malades (11 avec CG, cinq avec PKD, et six
avec CP), avec Scr 1, 7 a 4,1, suivis de 6 a 72 mois (moyenne, 24). Dans
l'analyse de regression entre l'inverse de la créatinine et le temps, les
pentes étaient de —0,0017, —0,0025, et —0,00016 dl/mg/mois dans les
trois groupes de malades en régime restreint en protides, respective-
ment. La difference entre les groupes 1 et 2 et le groupe 3 était
statistiquement significative (P < 0,05). Les pentes chez les malades en
régime libre étaient significativement plus élevées que celles trouvées
chez les malades en régime restreint en protides. La probabilité de
survie actuarielle a 72 mois, en définissant Ia "mort rénale" pour Scr de
10 mgldl, était de 45% chez les malades atteints de CG, 44% chez ceux
atteints de PKD et 67% chez ceux atteints de CP, en régime restreint en
protides. La protéinurie et l'hypertension étaient les facteurs
principaux affectant Ia progression de l'insuffisance rénale dans tous les
groupes de malades. Avec cc régime alimentaire, des pourcentages
substantiels de malades (51% dans le groupe 1,41% dans le groupe 2, et
68% dans le groupe 3) n'avaient pas de progression de la déténoration
fonctionnelle pendant Ic suivi.
In the last 9 years, the administration of a diet containing
about 40 kcal/kg, 0.6 g/kg of protein, and 700 mg of phosphate
was effective in delaying the progression of functional deterio-
ration in patients with early renal failure [1, 2].
The actuarial survival probability, assuming as "renal death"
a serum creatinine level of 10 mg!dl, in 149 patients with early
renal failure of diverse etiology followed for 22 to 98 months,
was found to be 72% at 72 months [3].
However, significant differences in the progression of renal
failure were observed in patients with various nephropathies,
probably due to the different pathophysiological mechanisms
which mediate the onset and the progression of renal failure in
chronic renal disease [4, 5].
This study was undertaken with the main purpose of identify-
ing the factors of progression of renal failure in three patient
groups with renal disease of diverse etiology (chronic glomeru-
lonephritis, polycystic kidney disease, primary chronic pye-
lonephritis) on long-term dietary protein restriction. In addi-
tion, the progression of renal failure had been compared with
that of a fourth patient group with the same renal disease,
evaluated by retrospective analysis, and kept on an unrestricted
diet.
Methods
Four patient groups with chronic renal failure (CRF) of
diverse etiology were studied; many of these patients were
included in a previous study [1].
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None exhibited clinical or biochemical evidence of diabetes
mellitus or other systemic diseases affecting the kidney.
Group 1. Thirty-three patients, 21 males and 12 females, aged
25 to 70 years (mean, 48), presented with chronic glomerulo-
nephritis (CG), proven with biopsy in all patients. The biopsy
specimens were analyzed by light microscopy, im-
munofluorescence, and electron microscopy [61. Thirteen pa-
tients had mesangial proliferative glomerulonephritis, nine
membranous nephropathy, five membranoproliferative glomer-
ulonephritis, and six patients had diffuse glomerular sclerosis.
All patients had radiologic evidence of bilateral reduction in
kidney size. Ten patients had clinical evidence of nephrotic
syndrome with proteinuria in excess of 3.5 g/24 hr; 23 patients
had minimal proteinuria (less than 1.5 g/24 hr). The initial serum
creatinine values ranged from 1.4 to 4.3 mg/dl (mean, 2.20) and
were found to be stable in three different determinations over 15
days. The mean arterial pressure was 108 mm Hg (54% of the
patients had diastolic blood pressure equal to or higher than 100
mm Hg).
Group2. Seventeen patients, 11 males and 6 females, aged 39
to 71 years (mean, 49), exhibited bilateral polycystic kidney
disease (PKD), diagnosed by history and clinical and radiologic
investigations. Six patients had persistent bacteriuria (Esch-
erichia coli and Proteus vulgaris). Initial serum creatinine
values were 1.3 to 4.7 mg/dl (mean, 2.40) and appeared to be
stable in three determinations over 14 days. The mean arterial
pressure was 114 mm Hg (70% of the patients had diastolic
blood pressure equal to or higher than 100 mm Hg).
Group 3. Twenty-eight patients, 19 males and 9 females, aged
37 to 66 years (mean, 54), with primary chronic pyelonephritis
(CP). The diagnosis was made by history, clinical and radiologic
data, and ultrasonography. These studies showed in all patients
the typical appearance of renal cortical scarring associated with
asymmetrical reduction in the kidney size. In none was there
evidence of stones, renal tuberculosis, analgesic nephropathy,
or vesico-ureteric refiux. Four patients had significant
bacteriuria (E. coli and Proteus vulgaris). The initial serum
creatinine values were 1.5 to 4.5 mg/dl (mean, 2.57), and the
mean arterial pressure was 112 mm Hg (50% of the patients had
diastolic blood pressure equal to or higher than 100 mm Hg).
Proteinuria ranging from 0.3 to 2.5 g/24 hr was present in 19
patients (68%).
All patients in the three groups were kept on a diet containing
about 40 kcal/kg of 0.6 g/kg of protein, 700mg of phosphate, and
1,000 to 1,500 mg of calcium, orally supplemented, The diet for
patients with nephrotic syndrome was supplemented with an
additional protein content of 0.5 g for each gram of proteinuria.
In addition, patients with sustained high blood pressure re-
ceived antihypertensive drugs (alphamethyldopa, clonidine,
propranolol, and prazosin), in some of them (and especially in
those with nephrotic syndrome) associated with furosemide. In
about 30% of all patients small doses of allopurinol were also
given. No patients received vitamin D or its analogues.
The followup ranged from 5 to 94 months (mean, 44) in
patients with CG, from 8 to 81 months (mean, 42.3) in those
with PKD and from 9 to 92 months (mean, 41) in those with CP.
Control group. Twenty-two patients in this group had serum
creatinine values of 1.7 to 4.1 mg/dl (mean, 2.05). Eleven
patients, seven males and four females, aged 30 to 65 years, had
CG; five patients, three males, and two females, aged 38 to 55
years, had bilateral PKD; and six patients, three males and
three females, had primary CP. The mean arterial pressure in
these subgroups was not different from that recorded in groups
1, 2, and 3.
All patients in the control group were referred to our units by
other colleagues. Since the discovery of renal failure, no
attempt to control progression by means of dietary restriction
had been done for 6 to 72 months (mean, 24). The estimated
dietary caloric, protein, phosphorus, and calcium intakes aver-
aged 35 kcal/kg, 70 g, 900 mg, and 800 mg/day, respectively.
The compliance of patients with the protein-restricted diet
was assessed according to the previously described methods [11
and was estimated to be satisfactory in more than 90% of the
patients. Those few patients with a poor compliance were
equally distributed in the three groups.
For the purpose of detecting changes in renal function, both
the reciprocal and logarithmic plots of serum creatinine against
time [7, 81 were calculated and displayed, and the reciprocal
plot, which had the better straight line, was used.
In addition, the theoretical "doubling-time" of initial serum
creatinine [8] and the actuarial survival probability [9] at 72
months, assuming as "renal death" a serum creatinine level of
10 mg/dl, were also evaluated. Statistical comparison of the
data was performed with the analysis of variance, Student's t
test, and the x2 test.
Serum creatinine was determined by means of an autoana-
lyzer (Technicon Instruments Corporation, Tarrytown, New
York, USA). Urine protein was assessed with the Ponceau Red
method. Nutritional status was evaluated according to previ-
ously described methods [1, 2].
Results
During a followup averaging 41 to 44 months, the slopes in
the regression analysis of reciprocal creatinine against time
were —0.0017 dl/mg/month in patients with CG, —0.0025
dI/mg/month in those with PKD, and —0.00016 dl!mg/month in
those with CP. The difference between groups 1 and 2 (CG and
PKD) and group 3 (CP) was statistically significant (P < 0.05).
The theoretical doubling-time of initial serum creatinine was 8.7
years in patients with CG, 8.5 years in patients with PKD, and
14.9 in those with CP.
The comparison with patients affected with the same renal
disease, retrospectively studied for a mean period of 24 months
on an unrestricted diet, showed significant differences in the
course of renal failure (Table 1). The actuarial survival prob-
ability at 72 months was 45% in patients with CG, 44% in
patients with PKD, and 67% in those with CP, on protein-
restricted diet.
The difference between the percentages in both patient
groups with CO and PKD and that of patients with CP was
statistically significant (P < 0.01).
The survival probability appeared to decrease at a progres-
sive, although different, rate in patients with CO and CP; it
remained well preserved for years, but decreased rapidly at a
later stage in those with PKD (Fig. 1).
Among patients with CG, those with nephrotic syndrome had
a slope in the regression analysis of reciprocal creatinine against
time significantly greater (—0.0027 dL/mg/month) than that
found in those with minimal proteinuria (—0.0015; F = 6.74; P
<0.05, Fig. 2). Among patients with CP, those with proteinuria
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Table 1. The course of renal failure in three patient groups on a protein-restricted diet (groups I to 3) as compared to that observed in patients
on an unrestricted diet (control group)
Patients on protein-restricted diet (Groups I to 3)
Patients on unrestricted diet
(Control group)
Group
Number of
patients
Scr at start Scr after follow up
mgldl mgldl
l/Scr slope
dl/mglmonth
Number of 1/Scr slope
patients dllmglmonth P
1 (CG)
2 (PKD)
3 (CP)
33
17
28
2.20 3.10
2.40 3.20
2.57 3.02
—0.0017
—0.0025
—0.00016
11
—0.019
5 —0.019
6 —0.003
<0.01
<0.01
<0.001
Abbreviations: CG, chronic glomerulonephritis; PKD, polycystic kidney disease; CP, chronic pyelonephritis; Scr, serum creatinine.
Group
Normotensive Hypertensive
Num- uSer slope
ber of dllmg/
patients month P
Num-
ber of
patients
l/Scr slope
dlImgI
month
1 (CG)
2 (PKD)
3 (CP)
8 (24%)
5 (29%)
12 (43%)
0.00006
—0.0006
0.00005
25 (76%)
12 (71%)
16 (57%)
—0.0029
—0.0059
—0.0027
<0.001
<0.01
<0.001
patients there was no progression of renal failure during the
followup.
The patients in the three groups were divided, according to
their blood pressure values at the beginning of the study, into
two categories, normotensive and hypertensive (diastolic blood
pressure 100 mm Hg). The progressive functional deteriora-
tion was significantly faster in patients with arterial hyper-
tension, regardless of their basic renal disease (Table 2). During
the followup, 13 patients on a protein-restricted diet (16.6%)
had to start regular dialysis treatment; serum creatinine con-
centration exceeded 10 mg/dl. They exhibited: CG (seven
patients, 21.2% of group 1); PKD (three patients, 17.6% of
group 2); CP (three patients, 10.7% of group 3).
In group 1, 16 patients, most of whom exhibited the nephrotic
10 20 o o syndrome, had progressive deterioration of renal function,
whereas in 17 patients (51%) there was no progression at all. In
group 2, progressive deterioration of renal function occurred in
ten patients, while the renal function remained stable in seven
of them (41%). In group 3, only nine patients, most of whom
had proteinuria, showed a progressive increase in serum cre-
atinine, whereas renal function remained stable in 19 patients
50 (68%).
The statistical analysis showed a significant difference be-
tween the percentage of patients with CP who did not have a
continued loss of renal function, and that of patients with PKD
(x2 = 3.96; P < 0.005; Table 3).
The rates of progression of renal failure in patients with
continued deterioration of renal function was not significantly
different in the three groups: —0.0074 dl/mg/month in patients
with CG, —0.0049 in patients with CP, and —0.0064 in those
with PKD (P = NS).
Among patients with continued deterioration of renal func-
Table 2. The course of renal failure in the three patient group on a
protein-restricted diet, divided according to initial
blood pressure values
Time, months
Fig. 1. Actuarial survival probability at 72 months in three patient
groups with early rena/failure on a protein-restricted diet (renal death
= Scr  10 mg/dl). The asterisk represents P < 0.01. Abbreviations
are: CP, chronic pyleonephritis; CG, chronic glomerulonephritis; PKD,
polycystic kidney disease.
Abbreviations: CG, chronic glomerulonephritis; PKD, polycystic6 12 18 24 30 36 42 48 54 60 66 72 kidney disease; CP, chronic pyelonephritis; Scr, serum creatinine.
7
6
1E 2.
a) 1
0
0
Follow-up, months
0.5
20 30 40
Follow-up, months
Fig. 2. Changes in serum creatinine and in the slope of reciprocal serum
creatinine against time in patients with chronic glomerulonephritis with
(O---O; slope —0.0027 dllmglmonth) and without (I—S; slope
—0.0015 dllmglmonth) nephrotic syndrome.
had a slope (— 0.0016 dl/mg/month) significantly greater than
that found in those without proteinuria (0.0015 dl/mg/month; t
= 3.53; P < 0.01). As a matter of fact, in this latter group of
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Table 3. Patients with chronic renal failure without progression of
functional deterioration during a long-term protein-restricted diet
Group
Number of
patients % x2 P
1 (CG) 17/33 51 CG vs. CP 1.70 NS
2 (PKD) 7/17 41 CG vs. PKD 0.51 NS
3 (CP) 19/28 68 CP vs. PKD 3.96 <0.05
Abbreviations: CG, chronic glomerulonephntis; PKD, polycystic
kidney disease; CP, chronic pyelonephritis; NS, not significant.
tion during the period of study (N = 35), 27 (77%) had
proteinuria and 31(88%) had "entry" high blood pressure.
Proteinuria was observed in 15 out of 43 patients without
progression of renal failure (35%) and "entry" hypertension in
22 of them (51%). The differences are statistically significant (x2
= 13.82 and 12.32, respectively; P < 0.001 in both cases).
No significant changes in nutritional measurements were
observed in patients on the protein-restricted diet.
Discussion
It is now evident that chronic renal disease may have its own
evolution either due to immunologic or non-immunologic fac-
tors [4, 5].
In patients with chronic glomerulonephritis, the persistent
immunologically mediated renal damage might be responsible
for the progressive deterioration of renal function.
Morphologic evidence of immunologically mediated renal
damage was observed in virtually all of our patients with
chronic glomerulonephritis. However, the progression of func-
tional deterioration was significantly faster in patients with
nephrotic syndrome than in those without proteinuria in the
nephrotic range. Thus, the magnitude of urinary protein losses
appears to be an important factor affecting deterioration of renal
function in patients with primary glomerular diseases of im-
munologic origin.
In patients with primary chronic pyelonephritis the course of
renal failure is substantially better than that observed in those
with either chronic glomerulonephritis or polycystic kidney
disease, regardless of their dietary protein intake. As a matter
of fact, primary chronic pyelonephritis accounts for only a
minority of all renal failure [10—12]. In these patients proteinuria
is considered to be a major factor responsible for a poor
prognosis as far as the occurrence and the progression of renal
failure are concerned [10].
Proteinuria was significantly important in promoting deterio-
ration of renal function, thus confirming other reports on its
adverse effect in prognosis in chronic pyelonephritis [13—15].
Proteinuria may reflect, to some extent, the degree of glomer-
ular sclerosis which follows the progressive reduction of the
nephron mass in any chronic renal disease [5]. In our patient
population with primary chronic pyelonephritis, an absence of
proteinuria was observed only in those who had no progression
of renal failure during the followup. The adverse role of
proteinuria, which is critical in patients with chronic glomerulo-
nephritis and very important in those with primary chronic
pyelonephritis, is probably less important in polycystic kidney
disease. In these patients, the rate of progression of renal failure
may vary with age and may be affected by the constant growth
of the cysts, secondary infections, and hypertension [16].
In our experience, infection did not appear to play a promi-
nent role in mediating functional deterioration in polycystic
kidney disease. In fact, clinically evident renal infection was
observed in 35% of the patients, but was followed by a
persistent rise in serum creatinine in only 15% of them. On the
contrary, hypertension was important in accelerating the pro-
gression of renal failure not only in patients with polycystic
kidney disease, but also in those with chronic glomerulo-
nephritis and chronic pyelonephritis.
The statistical analysis evaluating the course of renal failure
in the three patient groups on a protein-restricted diet, divided
into normotensive and hypertensive according to their initial
blood pressure values, showed that the rate of progression was
worse in this latter group, regardless of the basic renal disease.
It must be stressed that progression of renal failure was faster
in hypertensive patients despite the apparently good control of
blood pressure obtained by continued administration of
antihypertensive drugs. Therefore, our data indicate that hyper-
tension, which has been shown to produce renal damage by
directly affecting the glomerular vessels [17], may be a potential
factor accelerating functional deterioration in patients with
renal disease of diverse etiology. Whatever the mechanisms of
progression, an early dietary restriction in protein and phos-
phate may delay functional deterioration in all patients.
We are now following more than 200 patients with chronic
renal disease of diverse etiology, in whom the long-term (6 to
130 months) administration of a protein-restricted diet is ef-
fectively delaying the progression of functional deterioration
without the risk of malnutrition.
Although controlled prospective studies are lacking, we have
obtained clinical evidence, based on retrospective analysis, that
the average rate of decrease in reciprocal creatinine is ap-
proximately 11 times lower in patients with chronic glomerulo-
nephritis on a protein-restricted diet than in those on an
unrestricted diet, seven times lower in patients with polycystic
kidney disease and 19 times lower in those with chronic
pyelonephritis (Table I).
On the other hand, the survey of the literature shows that the
rate of progression in our patients on an unrestricted diet is
quite similar to that reported in patients with the same renal
disease without dietary restriction [7, 8, 11, 16]. When dietary
protein restriction is started early in the course of renal failure,
the progression of functional deterioration can be reduced, or
even halted, in a substantial percentage of patients, regardless
of the nature of the renal disease.
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